A Markov model for optimal intervals in prostate cancer screening programs in the era of individual baseline PSA values

被引:0
|
作者
Kobayashi, T
Goto-Watanabe, R
Ito, K
Mitsumori, K
机构
[1] Hamamatsu Rosai Hosp, Shizuoka, Japan
[2] Kyoto Univ, Grad Sch Econ, Kyoto, Japan
[3] Gunma Univ, Sch Med, Maebashi, Gumma 371, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:407S / 407S
页数:1
相关论文
共 47 条
  • [1] METASTATIC PROSTATE CANCER IN THE MODERN ERA OF PSA SCREENING
    Fontenot, Philip
    Nehra, Avinash
    Wyre, Hadley
    Mirza, Moben
    Holzbeierlein, Jeffrey
    Thrasher, J. Brantley
    Van Veldhuizen, Peter
    Lee, Eugene
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E824 - E825
  • [2] Metastatic prostate cancer in the modern era of PSA screening
    Fontenot, Philip A., Jr.
    Nehra, Avinash
    Parker, William
    Wyre, Hadley
    Mirza, Moben
    Duchene, David A.
    Holzbeierlein, Jeffrey
    Thrasher, James Brantley
    Van Veldhuizen, Peter
    Lee, Eugene K.
    [J]. INTERNATIONAL BRAZ J UROL, 2017, 43 (03): : 416 - 421
  • [3] Screening for prostate cancer in 2007: The PSA era and its challenges are not over
    Shariat, Shahrokh F.
    Karakiewicz, Pierre I.
    [J]. EUROPEAN UROLOGY, 2008, 53 (03) : 457 - 460
  • [4] Prostate cancer screening strategies with re-screening interval determined by individual baseline prostate-specific antigen values are cost-effective
    Kobayashi, T.
    Goto, R.
    Ito, K.
    Mitsumori, K.
    [J]. EJSO, 2007, 33 (06): : 783 - 789
  • [5] NATURAL HISTORY OF BIOCHEMICAL PERSISTENT PROSTATE CANCER DIAGNOSED IN THE ERA OF PSA SCREENING
    Kaul, Sanjeev
    Diaz, Mireya
    Patil, Nilesh
    Kheterpal, Emil
    Bhandari, Akshay
    Peabody, James
    Menon, Mani
    Rogers, Craig
    [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E333 - E333
  • [6] Prostate cancer screening strategies with rescreening interval determined by individual baseline prostate-specific antigen values are cost-effective
    Kobayashi, Takashi
    Goto, Rei
    Ito, Kazuto
    Ogawa, Osamu
    [J]. JOURNAL OF UROLOGY, 2007, 177 (04): : 66 - 66
  • [7] Lycopene, Tomato Products, and Prostate Cancer Incidence: A Review and Reassessment in the PSA Screening Era
    Wei, Melissa Y.
    Giovannucci, Edward L.
    [J]. JOURNAL OF ONCOLOGY, 2012, 2012
  • [8] Managing costs of prostate cancer screening programs: Implications of PSA level upper limit
    Chade, Daher C.
    Antunes, Alberto A.
    Vicentini, Fabio
    Piovesan, Affonso C.
    Cordeiro, Paulo
    Yamada, Renato T.
    Freire, Geraldo
    Srougi, Miguel
    [J]. JOURNAL OF UROLOGY, 2008, 179 (04): : 59 - 59
  • [9] Dynamics of Medical Screening: A Simulation Model of PSA Screening for Early Detection of Prostate Cancer
    Karanfil, Ozge
    [J]. SYSTEMS, 2023, 11 (05):
  • [10] Prostate-specific antigen (PSA) velocity: a test of controversial benefit in the era of increased prostate cancer screening
    Borofsky, Michael S.
    Makarov, Danil V.
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2011, 13 (04) : 614 - 615